Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: A nationwide cohort

Thorax

Volumn 64, Issue 3, 2009, Pages 271-

  Attamna, A ^a   Chemtob, D ^b   Attamna, S ^a   Fraser, A ^c   Rorman, E ^b   Paul, M ^c,d   Leibovici, L ^c,d  

^a CLALIT HEALTH SERVICES   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ISONIAZID; PYRAZINAMIDE;

HUMAN; INFECTION RISK; LETTER; MORBIDITY; MULTIDRUG RESISTANT TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 61649117959     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.100974     Document Type: Letter

References (4)

1. Fraser A, Paul M, Attamna A, et al. Treatment of latent tuberculosis in persons at risk for multidrug-resistant tuberculosis: systematic review. Int J Tuberc Lung Dis 2005;10:19-23.
2. Burgos M, DeRiemer K, Small PM, et al. Effect of drug resistance on the generation of secondary cases of tuberculosis, J Infect Dis 2003;188:1878-84.
3. Kritski AL, Marques MJ, Rabahi MF, et al. Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 1996;153:331-5.
4. Papastavros T, Dolovich LR, Holbrook A, et al. Adverse events associated with pyrazinamide and levofloxacin In the treatment of latent multidrug-resistant tuberculosis, CMAJ 2002;167:131-6.